Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

foreignpolicyjournal.com
foreignpolicyjournal.com > 08/02/2026 > fidelity-study-reveals-average-retiree-faces-185500-in-healthcare-costs

Fidelity Study Reveals Average Retiree Faces $185,500 In Healthcare Costs

4+ hour, 18+ min ago   (387+ words) By Ewan Scott | Aug 2, 2026 | Economy & Business, Featured, News & Analysis A new study from Fidelity estimates that the average 65-year-old retiring in 2026 will spend a staggering $185,500 out of pocket on healthcare throughout retirement. That figure represents one of the single largest…...

foreignpolicyjournal.com
foreignpolicyjournal.com > 05/29/2026 > cvs-health-nyse-cvs-reinstates-zepbound-coverage-and-adds-new-weight-loss-pill-to-drug-plans

CVS Health (NYSE: CVS) Reinstates Zepbound Coverage And Adds New Weight-Loss Pill To Drug Plans

2+ mon, 4+ day ago   (427+ words) By David Prior | May 29, 2026 | Economy & Business, Featured, News & Analysis CVS Health (NYSE: CVS) announced it will reinstate coverage of Eli Lilly’s weight-loss injectable Zepbound and begin covering the anti-obesity pill Foundayo for millions of Americans on private insurance plans. Coverage…...